Skip to main content

NIH Grants for Pharmacogenomics Research FY 06 Mar. 12 -- April 9*

Premium
NIH Grants for Pharmacogenomics Research FY'06
Mar. 12 — April 9*
City, State, or Country Name
Organization Name
Principal Investigator
Award
Title
California
Portola Valley
Gene Security Network Rabinowitz, Matthew $218,859 Integrating, Validating & Applying Pharmacogenetic Data
San Francisco University of California
San Francisco
Hamilton,
Steven P
$1,764,980 Pharmacogenomics of Antidepressant Response
Mountain View Perlegen Sciences Stokowski, Renee P $1,144,992 Signature SNPs to distinguish Yersinia pestis strains
La Jolla University of California
San Diego
Nigam,
Sanjay K
$339,181 SNPs in Handling of Small Pox Antivirals & Other Drugs
University of California
San Diego
Yuan,
Jason Xj
$150,788 SNPs in Idiopathic Pulmonary Artierial Hypertension
Florida
Tampa
H. Lee Moffitt Cancer Center Bepler,
Gerold
$286,873 Pharmacogenomics of Neoadjuvant Gemcitabine-Pemetrexed
Edgerton,
Mary E
$217,802 Clinical & Microarray Data Predict Lung Cancer Outcomes
Massachusetts
Boston
Dana-Farber Cancer Institute Johnson,
Bruce E
$289,347 EGFR Mutations in non-Small Cell Lung Cancer
Meyerson, Matthew L $325,631 Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
Tufts University Greenblatt, David J $232,163 CYP3A Function in Aging African Americans
Michigan
Ann Arbor
University of Michigan at
Ann Arbor
Waskell,
Lucy A
$296,151 Participation of Cytochrome b5 in Anesthetic Metabolism
New Hampshire
Hanover
Dartmouth College Hwa, John $312,285 Pharmacogenetics of the human prostacyclin receptor.
Pennsylvania
Philadelphia
Wistar Institute Showe,
Louise C
$311,770 Microarray Analysis of Responsiveness of CTCL IL-12
Tennessee
Memphis
St. Jude's Children's Research Hospital Schuetz,
Erin G
$286,300 PXR: Regulation and Pharmacogenomics
Texas
Houston
University of Texas MD Anderson Cancer Center Cinciripini,
Paul M
$531,714 Pharmacogenetics, Emotional Reactivity & Smoking
The Woodlands Molecular Logix Pienkos,
Philip T
$401,535 Creating Clinically Relevant EGFR Antagonists
Virginia
Richmond
Virginia Commonwealth University Manjili,
Masoud H
$229,888 Enhancement of HER-2/neu-based therapy using HSP11
Washington
Pullman
Washington State University Jones,
Jeffrey P
$270,730 Cytochrome P450 Models for Risk Assessment
Seattle University of Washington Rettie,
Allan E
$327,944 Pharmacogenetics of ADRs: Warfarin Toxicity
Fred Hutchinson Cancer Research Center Potter,
John D
$842,309 Aspirin, UGT1A6 Genotype, and Colon Gene Expression
Wisconsin
Milwaukee
Medical College of Wisconsin Stephens, Michael C $126,900 ABC Transporter Pharmacogenetics: Impact on Thiopurine Therapy
*SOURCE: US National Institutes of Health

Filed under

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.